US Markets

Health Care Sector Update for 08/03/2020: IMUX

Health care firms were advancing premarket Monday with the Health Care SPDR (XLV) up 0.55% and the iShares NASDAQ Biotechnology Index (IBB) 0.82% higher in recent trading.

Immunic (IMUX) was gaining more than 37% in value after saying its phase 2 study of the drug IMU-838 in patients with relapsing-remitting multiple sclerosis achieved all of its primary and key secondary endpoints. Separately, Immunic posted a net loss of $0.90 per share for the three months ended June 30, compared with a loss of $1.52 per share a year earlier. Analysts polled by Capital IQ expected a loss of $0.69 per share.

Varian Medical Systems (VAR) was rallying past 22%. The company said Sunday it agreed to be acquired by Siemens Healthineers in a $16.4 billion all-cash transaction. Separately, Varian reported fiscal Q3 non-GAAP earnings of $0.78 per share, down from $1.32 a year earlier but beating the Capital IQ analyst consensus of $0.52.

McKesson (MCK) was more than 4% higher as it reported fiscal Q1 adjusted earnings of $2.77 per share, declining from $3.31 a year earlier. Analysts polled by Capital IQ had an average earnings estimate of $2.39 per share.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

IMUX

Latest Markets Videos

MTNewswires

Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

Learn More